Status:
COMPLETED
Herpesvirus in Idiopathic Pulmonary Fibrosis
Lead Sponsor:
Emory University
Conditions:
Lung Diseases
Herpesvirus Infections
Eligibility:
All Genders
Brief Summary
The purpose of this study is to: 1) to develop a method to quantify Epstein Barr Virus (EBV) load in lung tissue of humans and to determine whether EBV viral load is significantly higher in lung tissu...
Detailed Description
IPF is a progressive disease where there is no proven treatment, other than lung transplant. Doctors do not know what causes IPF. We think that IPF is caused by a viral infection, particularly herpes ...
Eligibility Criteria
Inclusion
- For the study on lung tissue, eligible subjects were IPF patients undergoing lung transplant surgery and from organ donors who died from non-pulmonary causes. For the study in clinic, subjects were IPF patients who had no other pulmonary disease other than IPF and the diagnosis of IPF was confirmed by lung biopsy or by clinical and chest CT findings. The control group consisted of subjects without respiratory symptoms or pulmonary diseases who were the household partner or spouse of an enrolled IPF subject and accompanied the IPF patient to outpatient clinic visits.
- Exclusion Criteria:
- Failure of the patient to provide informed consent.
Exclusion
Key Trial Info
Start Date :
July 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2012
Estimated Enrollment :
41 Patients enrolled
Trial Details
Trial ID
NCT00228670
Start Date
July 1 2005
End Date
August 1 2012
Last Update
May 11 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Emory University
Atlanta, Georgia, United States, 30322